Syntekabio

About:

Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.

Website: http://www.syntekabio.com

Twitter/X: syntekabio

Top Investors: Altos Ventures, Korea Development Bank, Smilegate Investment, Korea Investment Partners, KB Securities

Description:

Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.

Total Funding Amount:

$212M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Daejeon, Taejon-jikhalsi, South Korea

Founded Date:

2009-09-15

Contact Email:

admin.usa(AT)syntekabio.com

Founders:

Jongsun Jung

Number of Employees:

11-50

Last Funding Date:

2024-04-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai